GENVEC, INC.
NASDAQ:GNVC
$2.60
-$0.04
(-1.61%)
Quote as of 11:35 AM EST on 02/10/12
|
$2.60
-$0.04
(-1.61%)
|
|
| Today's Open | $2.62 |
|---|---|
| Previous Close | $2.64 |
| Daily Range | $2.59 - $2.62 |
| 52-Week Range | $2.00 - $5.60 |
| Market Cap | $33.66M |
| P/E Ratio | -5.50 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 3,442 |
| Average Daily Volume | 26,334 |
| Current FY EPS | -$0.52 |
GNVC Information
| Description |
|---|
| A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Life Sciences Companies Raise Record Amounts of Capital
GenVec, Merial Team up to Develop Food-and-Mouth Disease Vaccine
Amgen, Celgene and Novartis in the Fight Against Pancreatic Cancer
Competitive Technologies: Short Squeeze Coming or Another Leg Down?
Stocks Claw Back to End Day Lower, Week Higher
UPDATE 1-GenVec shrs plunge after cancer drug trial discontinued
UPDATE 1-GenVec says cancer drug not effective, ends trial
GenVec Halts Phase III Trial Of TNFerade For Pancreatic Cancer
UPDATE 1-GenVec to raise $26.2 mln from offering
GenVec Unveils Novartis Partnership On Hearing-Loss Treatment
